Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 7, keine Gesamtzahl für „women“
Suchtreffer
Begriffe & Kennungen
Leflunomide medac · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenLeflunomide medac · 4.3 · • Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment
Eintrag öffnenLeflunomide ratiopharm · 4.3 · • Breast-feeding women (see section 4.6).
Eintrag öffnenLeflunomide ratiopharm · 4.3 · • Pregnant women, or women of childbearing potential who are not using reliable contraception during treatment
Eintrag öffnenLenalidomide Accord · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Women who are
Eintrag öffnenLenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. - Women who are
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. - Women who are
Eintrag öffnenLenalidomide Mylan · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1 Women who are p
Eintrag öffnenLonsurf · 4.5 · It is unknown whether Lonsurf may reduce the effectiveness of hormonal contraceptives. Therefore, women using
Eintrag öffnenLuveris · 4.8 · Ectopic pregnancy may also occur, especially in women with a history of prior tubal disease.
Eintrag öffnenLydisilka · 4.5 · - Long-term treatment In women on long-term treatment with hepatic enzyme-inducing active substances, another
Eintrag öffnenLydisilka · 4.5 · - Short-term treatment Women on treatment with enzyme-inducing medicinal products should temporarily use a bar
Eintrag öffnenLydisilka · 4.8 · The following serious adverse reactions have been reported in women using CHCs, which are discussed in section
Eintrag öffnenLynkuet · 4.8 · The safety profile of elinzanetant is based on data from women who received at least 1 dose of 120 mg elinzane
Eintrag öffnenLysodren · 4.8 · Premenopausal women Non-malignant ovarian macrocysts (with symptoms such as pelvic pain, vaginal bleeding, men
Eintrag öffnenMißhandelte Frauen
Eintrag öffnenMovymia · 4.8 · In a large clinical trial, antibodies that cross-reacted with teriparatide were detected in 2.8% of women rece
Eintrag öffnenMyclausen · 4.3 · 21 • Myclausen should not be given to women of childbearing potential who are not using highly effective contr
Eintrag öffnenMyclausen · 4.3 · • Myclausen should not be given to women of childbearing potential who are not using highly effective contrace
Eintrag öffnenMyclausen · 4.3 · • Myclausen should not be given to women who are breast-feeding (see section 4.6).
Eintrag öffnen